<DOC>
	<DOCNO>NCT01206595</DOCNO>
	<brief_summary>The primary objective study determine appropriate dose SKY0402 administer nerve block management postoperative pain follow bunionectomy .</brief_summary>
	<brief_title>Safety , Efficacy , Pharmacokinetics SKY0402 Administered Nerve Block Subjects Undergoing Bunionectomy</brief_title>
	<detailed_description>This Phase 2 , multicenter , randomize , double blind , dose escalating/de-escalating study evaluate safety , efficacy , pharmacokinetics single dose SKY0402 compare single 125 mg dose bupivacaine HCl treatment postoperative pain subject undergoing bunionectomy . Up 88 subject randomize five consecutive cohort . The dose bupivacaine HCl ( 125 mg ) remain constant cohort . After completion Cohort 1 , decision increase decrease dose SKY0402 make Cohort Data Review Committee follow review pharmacokinetic , safety , select efficacy data previous cohort . Study drug administer ankle block , without tourniquet , 1 hour induction general anesthesia 20 minute end general anesthesia . The ankle block procedure consist five injection via three skin entry target follow nerve : posterior tibial , sural , deep peroneal , superficial peroneal , saphenous . The use intravenous fentanyl general anesthesia permit , exceed 250 microgram . The intraoperative use morphine prohibit . Postoperatively , subject access opioid non-opioid supplemental pain medication general guideline . Blood sample determination plasma bupivacaine concentration obtain Baseline specify time point 96 hour .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Subjects eligible enrollment meet follow criterion : 1 . Males females â‰¥18 year age Screening Visit . NOTE : Eligible female postmenopausal surgically sterile , , child bear potential , pregnant nursing , agree become pregnant study use acceptable mean contraception least 1 month 1 month dosing , include follow : hormonal contraceptive ( oral , injectable , implantable ) , effective barrier method ( e.g. , condom spermicide ) , intrauterine device ( IUD ) , lifestyle personal choice abstinence , nonheterosexual lifestyle , strictly monogamous relationship partner vasectomy . 2 . Scheduled undergo primary unilateral first metatarsal bunionectomy repair general anesthesia , without internal fixation . NOTE : For purpose protocol , surgical procedure involve osteotomy first metatarsal ( significant bone resection , excision , surgical fracture , etc . ) fusion first metatarsal phalangeal joint consider qualified procedure , whether perform specifically repair bunion ( hallus valgus deformity ) . Surgical technique accompany minimal bone excision ( e.g . cheilectomy ) procedure limit soft tissue repair eligible study . 3 . American Society Anesthesiology ( ASA ) Physical Class 1 2 . 4 . Able willing comply study visit procedure . 5 . Capable speak understanding local language sufficiently provide response pain assessment scale . 6 . Willing capable provide write informed consent . Subjects exclude study meet follow criterion : 1 . Clinically significant electrocardiogram ( ECG ) abnormality Screening Day 1 ( dose ) . 2 . Albumin and/or alpha 1 acid glycoprotein ( AAG ) normal level . 3 . Current historical evidence clinically significant disease condition , opinion Investigator , might increase risk surgery complicate subject 's postoperative course . 4 . Opioid medication usage 7 day period precede administration study drug . 5 . Current medical condition could require treatment analgesic medication postoperative period pain surgically relate ( e.g. , rheumatoid arthritis ) . 6 . Body mass index &gt; 30 mg/kg2 . 7 . Body weight less 60 kilogram . 8 . History hypersensitivity idiosyncratic reaction amide type local anesthetic agent . 9 . History hypersensitivity , idiosyncratic reaction , contraindication pain control agent ( opioid nonopioid ) anticipate use postoperatively . These contraindication may include follow : angioedema bronchospastic reactivity nonsteroidal antiinflammatory drug ( NSAID ) , peptic ulcer ( active within last 3 month ) , hepatic renal insufficiency . 10 . Coagulation disorder ongoing anticoagulation treatment . 11 . Administration investigational drug within 30 day 5 half life ( elimination ) , whichever longer , prior study drug administration . 12 . Suspected known history substance abuse and/or alcoholism .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Postoperative Pain</keyword>
	<keyword>Bunionectomy</keyword>
	<keyword>Analgesia</keyword>
</DOC>